Skip to main content

Table 1 The patients characteristics

From: Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative data

Variable

Vaule

 

median

age, years

68

PSA ng/mL

11.06

f/t PSA

0.13

PSAD ng/mL/mL

0.24

Gleason score

frequency

 BPH

174

 score 6

34

 score 7

74

 score 8

47

 score 9

22

 score 10

6

PI-RADSv2 score

 1–2

154

 3

35

 4–5

168

  1. IQR interquartile range, mpMRI multiparametric magnetic resonance imaging, PI-RADS v2 The Prostate Imaging Reporting and Data System Version 2, BPH benign prostatic hyperplasia